483
ADMIADMI – FDA 483, Jun 3, 2022
Record Details
An FDA inspection of ADMI, a manufacturer in East Syracuse, NY, from May 26 to June 3, 2022, identified significant deficiencies in the firm's quality system. Observations included a failure to maintain and provide accessible records, a lack of established procedures for device history records, and an absence of equipment maintenance schedules. These issues indicate a concerning lack of control over critical manufacturing processes and documentation.
View Company Profile
ID · 5300e8c6-704a-4995-8686-da8517387865
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.